Literature DB >> 17554059

High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism.

Takakazu Kawase1, Yasuo Morishima, Keitaro Matsuo, Koichi Kashiwase, Hidetoshi Inoko, Hiroh Saji, Shunichi Kato, Takeo Juji, Yoshihisa Kodera, Takehiko Sasazuki.   

Abstract

In allogenic hematopoietic stem-cell transplantation, an effect of HLA locus mismatch in allele level on clinical outcome has been clarified. However, the effect of each HLA allele mismatch combination is little known, and its molecular mechanism to induce acute graft-versus-host disease (aGVHD) remains to be elucidated. A total of 5210 donor-patient pairs who underwent transplantation through Japan Marrow Donor Program were analyzed. All HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 alleles were retrospectively typed in all pairs. The impacts of the HLA allele mismatch combinations and amino acid substitution positions in 6 HLA loci on severe aGVHD were analyzed. A total of 15 significant high-risk HLA allele mismatch combinations and 1 HLA-DRB1-DQB1 linked mismatch combinations (high-risk mismatch) for severe aGVHD were identified, and the number of high-risk mismatches was highly associated with the occurrence of severe aGVHD regardless of the presence of mismatch combinations other than high-risk mismatch. Furthermore, 6 specific amino acid substitution positions in HLA class I were identified as those responsible for severe aGVHD. These findings provide evidence to elucidate the mechanism of aGVHD on the basis of HLA molecule. Furthermore, the identification of high-risk mismatch, that is, nonpermissive mismatch, would be beneficial for the selection of a suitable donor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554059     DOI: 10.1182/blood-2007-02-072405

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  88 in total

1.  Donor registries and search strategies.

Authors:  Carolyn K Hurley; Machteld Oudshoorn; Michelle Setterholm
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.

Authors:  Doreen Haase; Mireille Starke; Kia Joo Puan; Tuck Siong Lai; Olaf Rotzschke
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation.

Authors:  Junya Kanda
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

4.  Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.

Authors:  K Kawamura; J Kanda; S Fuji; M Murata; K Ikegame; K Yoshioka; T Fukuda; Y Ozawa; N Uchida; K Iwato; T Sakura; M Hidaka; H Hashimoto; T Ichinohe; Y Atsuta; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

Review 5.  Allogeneic hematopoietic cell transplantation: the state of the art.

Authors:  Boglarka Gyurkocza; Andrew Rezvani; Rainer F Storb
Journal:  Expert Rev Hematol       Date:  2010-06       Impact factor: 2.929

6.  HLA-A amino acid polymorphism and delayed kidney allograft function.

Authors:  Malek Kamoun; John H Holmes; Ajay K Israni; Jane D Kearns; Valerie Teal; Wei Peter Yang; Sylvia E Rosas; Marshall M Joffe; Hongzhe Li; Harold I Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

7.  A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

Authors:  Carolina Martínez-Laperche; Elena Buces; M Carmen Aguilera-Morillo; Antoni Picornell; Milagros González-Rivera; Rosa Lillo; Nazly Santos; Beatriz Martín-Antonio; Vicent Guillem; José B Nieto; Marcos González; Rafael de la Cámara; Salut Brunet; Antonio Jiménez-Velasco; Ildefonso Espigado; Carlos Vallejo; Antonia Sampol; José María Bellón; David Serrano; Mi Kwon; Jorge Gayoso; Pascual Balsalobre; Álvaro Urbano-Izpizua; Carlos Solano; David Gallardo; José Luis Díez-Martín; Juan Romo; Ismael Buño
Journal:  Blood Adv       Date:  2018-07-24

8.  The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.

Authors:  Julia Pingel; Tao Wang; Yvonne Hagenlocher; Camila J Hernández-Frederick; Arnon Nagler; Michael D Haagenson; Katharina Fleischhauer; Katharine C Hsu; Michael R Verneris; Stephanie J Lee; Mohamad Mohty; Emmanuelle Polge; Stephen R Spellman; Alexander H Schmidt; Jon J van Rood
Journal:  Bone Marrow Transplant       Date:  2018-10-02       Impact factor: 5.483

Review 9.  Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.

Authors:  John A Hansen; Effie W Petersdorf; Ming-Tseh Lin; Steven Wang; Jason W Chien; Barry Storer; Paul J Martin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

10.  Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials.

Authors:  Takahiko Nakane; Hirohisa Nakamae; Takuhiro Yamaguchi; Saiko Kurosawa; Atsuo Okamura; Michihiro Hidaka; Shigeo Fuji; Akio Kohno; Takeshi Saito; Yasutaka Aoyama; Kazuo Hatanaka; Yoshio Katayama; Kimikazu Yakushijin; Toshimitsu Matsui; Motohiro Yamamori; Akiyoshi Takami; Masayuki Hino; Takahiro Fukuda
Journal:  Int J Hematol       Date:  2016-12-09       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.